An Ontology-Enabled Approach for Modelling Business Processes

International audienceColoured Petri Nets (CPNs) have formal semantics and can describe any type of workflow system, behavioral and syntax wise simultaneously. They are widely studied and successfully applied in modelling of workflows and workflow systems. There is an inherent problem regarding business processes modelled with CPNs sharing and subsequently their reuse need to be considered. The Semantic Web technologies, such as ontologies, with their characteristics demonstrate that they can play an important role in this scenario. In this paper, we propose an ontological approach for representing business models in a meta-knowledge base. Firstly, the CPN ontology is defined to represent CPNs with OWL DL. Secondly, we introduce four basic types of manipulation operations on process models used to develop and modify business workflow patterns. To the best of our knowledge, representing business process definitions and business workflow patterns as knowledge based upon ontologies is a novel approach

SOFC development program at Haldor Topsøe/Risø National Laboratory - progress presentation

The SOFC technology under development at Haldor Topsøe A/S and Risø National Laboratory is based on an integrated approach ranging from manufacturing of planar anode-supported cells and compact stacks to analysis of total systems. Today, the consortium of Haldor Topsøe A/S and Risø has an extended program to develop the SOFC technology all the way to a marketable product. The standard cells are thin and robust with dimensions of 12 x 12 cm2 and the cell stacks are based on internal manifolding. Production of cells in a pilot production plant is being up-scaled continuously. Stack and system modelling including cost optimisation analysis is used to develop 5 kW stack modules for operation in the temperature range 700-850°C. High volume power density stacks based on thin plate metallic interconnects have been tested formore than 10000 hours including thermal cycling with encouragingly small degradation. Stacks in the 1+ kW size classes have been tested in methane as well as CO rich gas. The SOFC program comprises development of next generation cells and multi stack modules for operation at lower temperature with increased durability and mechanical robustness. Development of cells with porous metallic support and new cathode materials is in progress in order to ensure long-term competitiveness

Gendering the careers of young professionals: some early findings from a longitudinal study. in Organizing/theorizing: developments in organization theory and practice

Wonders whether companies actually have employees best interests at heart across physical, mental and spiritual spheres. Posits that most organizations ignore their workforce – not even, in many cases, describing workers as assets! Describes many studies to back up this claim in theis work based on the 2002 Employment Research Unit Annual Conference, in Cardiff, Wales

Repositioning of the global epicentre of non-optimal cholesterol

High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.</p

Repositioning of the global epicentre of non-optimal cholesterol

High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol�which is a marker of cardiovascular risk�changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95 credible interval 3.7 million�4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world. © 2020, The Author(s), under exclusive licence to Springer Nature Limited